Track topics on Twitter Track topics that are important to you
Repligen Corporation is a biotechnology company focused on developing new drugs for debilitating pediatric disorders including autism, immune and metabolic disorders. Repligen has exclusive worldwide rights to market SecreFlo™, which was recently approved by the FDA for pancreatic assessment and manufactures and markets a set of patented products based on Protein A, which are used by the pharmaceutical industry to produce therapeutic antibodies.
41 Seyon Street Building #1
United States of America
Phone: (781) 250-0111
Fax: (781) 250-0115
Repligen said today it plans to merge with privately-held Spectrum Laboratories, in an approximately $359 million deal that Repligen said will accelerate the growth of its filtration business and enha...
Repligen Corporation and Check-Cap are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, di...
Spectrum recorded revenue of $40.2 million in 2016, with greater than 90% coming from its filtration product portfolio. The addition of Spectrum is expected to accelerate the growth of Repligen's ...
Bioprocessing company Repligen intends to raise gross proceeds of approximately $120m through an underwritten public offering of shares of its common stock.
US biologics specialist Repligen has entered into a definitive merger agreement with privately-held Spectrum…
Repligen Corporation has announced it will acquire filtration-focused Spectrum Pharmaceuticals for approximately $350m (€312m).
Repligenâs customer GE Healthcare opted to make its latest Protein A ligand in-house, but CEO Tony Hunt remains confident in his firmâs long-term partnerships and diversified bioprocessing offering.
A $359 million merger deal between Repligen and Spectrum Laboratories is expected to strengthen the companies' position in th -More-
Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for neurological disorders. In addition, we are the world's leading supplier of recombinant Protei...
Repligen Corporation is a biotechnology company focused on developing new drugs for debilitating pediatric disorders including autism, immune and metabolic disorders. Repligen has exclusive worldwide ...
We have published hundreds of Repligen news stories on BioPortfolio along with dozens of Repligen Clinical Trials and PubMed Articles about Repligen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Repligen Companies in our database. You can also find out about relevant Repligen Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...